CoreFirst Bank & Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
CoreFirst Bank & Trust's AMGN Position: Q1 2026 in Review
CoreFirst Bank & Trust reduced its Amgen (AMGN) stake by 9.3% in Q1 2026, selling an estimated $96.3K and leaving 2,633 shares worth $926K. The position accounts for 0.49% of the portfolio, ranked #47.
CoreFirst Bank & Trust first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.62M in Q1 2021. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- CoreFirst Bank & Trust held 2,633 shares of Amgen worth $926K as of Q1 2026.
- CoreFirst Bank & Trust sold 270 Amgen shares in Q1 2026, an estimated $96.3K.
- Amgen made up 0.49% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #47 holding.
- CoreFirst Bank & Trust first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
- CoreFirst Bank & Trust's Amgen position peaked at $1.62M in Q1 2021.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.